Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consolidative Prostate Radiotherapy in Patients With Metastatic Prostate Cancer

NCT05656794 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05656794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05656794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consolidative Prostate Radiotherapy in Patients With Metastatic Prostate Cancer
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Recruiting
Start date
August 9, 2023
Completion date
August 31, 2031
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate metastases